APSN / CSN CME Course 2019
Date: 19-21 September 2019
Venue: Hangzhou, China (exact location to be advised)
Information will be announced in due course.
APSN / HKSN CME Course 2019
Date: 28 September 2019
Venue: Hong Kong (exact location to be advised)
For enquiries, please send email to email@example.com
17th Congress of the International Society for Peritoneal Dialyisi ISPD
May 5, 2018 – May 8, 2018
Preliminary Program: http://ispdvancouver2018.org/program/
Early bird registration closes January 31, 2018
Standard registration closes April 6, 2018
On behalf of KidGen I would like to invite you to the Renal Genetics Symposium to be held at the Royal Children’s Hospital, Melbourne on the 3rd and 4th of November 2016. This year the symposium has expanded and over 2-days will feature talks by clinicians, scientists and researchers from across Australia. It is aimed at nephrologists, geneticists, genetic counsellors, metabolic physicians, and researchers interested in kidney development and disease, metabolic kidney disease and functional genomics.
Despite the packed programme there will be time for questions and debate, each session will be chaired by both a scientist and a clinician which will lend itself to broad ranging discussion of the topics.
The schedule is broad, with sessions devoted to cystic kidney disease, nephrotic syndrome, functional genomics, registries, and metabolic kidney disease. But within each session there is great depth, as excellent speakers will cover different aspects of each topic. For example, within the registries session Prof Stephen McDonald will discuss what an established registry, ANZDATA, can offer to genetics, Dr Hugh McCarthy will outline the aims of ARRK, Mr Sebastian King will explain his disease specific registry focussing on VACTERL, Prof Rowan Walker will discuss the role of inherited kidney disease in ROKD and Ass Prof Allison Tong will examine patient perspectives on genetic kidney disease.
I encourage you to read the schedule (available online at www.kidgen.org.au) and then register for the symposium using the link below. Numbers are limited so please register early.
For the first year we are charging a fee to attend the symposium, reflecting the growing interest in this topic, and this will enable us to provide catering which will facilitate discussion and networking at breaks. If you feel that you should be eligible for a concession, please don’t hesitate to email me at KidGen@rch.org.au.
For those travelling from interstate or overseas a limited number of rooms have been held in the Larwill hotel adjacent to the Royal Children’s Hospital. These can be booked by ringing the reservations team directly on (03) 9032 9111 or emailing firstname.lastname@example.org and quoting the meeting name “Renal Genetics Symposium” before the end of August.
A limited number of childcare places may be available for children under 5-years, if you are interested please email KidGen@rch.org.au with “Childcare Query” as the subject line, before the end of August. Expressing facilities are also available onsite.
ANZSIN Bulletin – April 2016
Welcome to the first newsletter for 2016.
Mission of ANZSIN (Australia and New Zealand Special Interest Group in Interventional Nephrology). The promotion and safe application of interventional procedures in order to improve the care and outcome of patients with kidney disease.
Aims: Provide leadership and promote education and research in interventional nephrology through our objectives, which include: development of and coordinating training programmes, ongoing education, developing clinical outcome monitoring programmes and accreditation standards. We will promote Nephrology and Interventional nephrology in particular as a career choice.
9th ANZSIN annual meeting (Perth, WA. 21-23 September 2016)
On behalf of the organising executive committee I am delighted to invite and encourage you to attend the next interventional nephrology meeting – planned for Wednesday afternoon 21 to Friday 23 September 2016. As with previous years, our meeting follows our parent society (ANZSN) annual scientific meeting.
Dr Akira Miyata, Director of Nephrology, Kumamoto, Japan is our overseas guest speaker. Dr Miyata has extensive skills in trauma and interventional vascular treatment. He brings a wealth of knowledge and experience to our meeting. We look forward to his presentations sharing his wide and varied practical knowledge.
The ANZSIN conference will be held at Fraser Suites, with both the conference meeting facilities and accommodation at the one-site venue – juxtaposition to the Swan River. Fraser Suites are a new development in a relaxing environment situated only 3km away from the Perth Convention Centre (site of the main ANZSN meeting); within the free-transit public transport zone of Perth permitting the freedom to enjoy the local city facilities in conjunction with your conference visit.
For more information on this year’s meeting – visit:
This year’s 52nd ANZSN annual scientific meeting is a combined meeting with the APSN’s 15th APCN; and coupled with this exciting joint meeting will be our 9th annual meeting. We do hope you will be able to attend this progressive and stimulating week of nephrology to both extend your knowledge in nephrology and then join us for a varied and interesting interventional nephrology meeting with our hands-on workshop.
12th ASDIN annual scientific meeting (Phoenix, Arizona. 19-21 February 2016)
Dr Steve May and I attended this American meeting held in Phoenix in February this year. Dr May will present at our 9th ANZSIN interventional meeting some of the high-lights from the 12th ASDIN meeting.
ANZSIN modelled our meeting on the ASDIN format. If you have been to or heard about an ASDIN meeting before, I am sure this will encourage you to attend the 9th ANZSIN meeting in Perth in September.
The ASDIN meeting in Phoenix covered much in the complications of haemodialysis access and their management; and peritoneal dialysis access and similarly complication management. Topics of unique management and discussion included: developments in haemodialysis stent grafts and their patency rates; innovations in access patency therapies; management of repeated complications of access; and training within the interventional specialty. Guest speaker Dr Maurzio Gallieni of Milan, Italy gave a fascinating review of development of vascular access since the onset of haemodialysis.
The meeting discussion sessions – as in previous years – permit the various interventional techniques, their pros and cons to be aired within the group of varied experience and knowledge. The opportunity to meet and talk to these experienced interventionists and select the ‘best of the best’ techniques to incorporate into one’s own individual practice is immense; and makes the attendance at interventional meetings so valuable. The hands on session we will have at our ANZSIN meeting on Friday 21 September will hopefully be of potentially similar benefit to you.
For more information of the ASDIN society, their activities and future activities programme, visit: http://www.asdin.org/
David Voss ED*** FRACP
Chair of ANZSIN Special Interest Group